|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 151.00 USD | -0.15% |
|
+3.65% | +23.02% |
| 09-03 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
Upcoming dividends: Gilead Sciences, Inc.
| 2026-09-15 | Ex-dividend date | US$0.82 Payment date: 2026-09-28 | 00:00 |
EPS & Dividend: Gilead Sciences, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.84 | 2.92 | 3 | 3.08 | 3.16 | 3.296 | 3.396 | 3.102 |
| Rate of return | 3.91% | 3.4% | 3.7% | 3.33% | 2.57% | 2.18% | 2.25% | 2.05% |
| EPS 2 | 4.93 | 3.64 | 4.5 | 0.38 | 6.78 | -3.273 | 8.021 | 8.705 |
| Distribution rate | 57.6% | 80.2% | 66.7% | 811% | 46.6% | -101% | 42.3% | 35.6% |
| Reference price 2 | 72.61 | 85.85 | 81.01 | 92.37 | 122.74 | 151.00 | 151.00 | 151.00 |
| Nbr of stocks (in thousands) | 1,254,384 | 1,254,244 | 1,246,042 | 1,246,266 | 1,240,680 | 1,239,955 | - | - |
| Announcement Date | 2/1/22 | 2/2/23 | 2/6/24 | 2/11/25 | 2/10/26 | - | - | - |
Past dividends: Gilead Sciences, Inc.
| 2026-06-15 | Ex-dividend date - 0.82 USD | 00:00 |
| 2026-03-13 | Ex-dividend date - 0.82 USD | 00:00 |
| 2025-12-15 | Ex-dividend date - 0.79 USD | 00:00 |
| 2025-09-15 | Ex-dividend date - 0.79 USD | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 2.18% | 2.25% | -46.14x | 10.28x | 6.65x | |
| 0.6% | 0.67% | 32.72x | 20.76x | 11.9x | |
| 1.95% | 2.04% | 30.62x | - | - | |
| 2.67% | 2.81% | 32.73x | -359.23x | 7.6x | |
| 2.8% | 2.86% | 19.89x | 7.15x | 4.73x | |
| 2.7% | 2.81% | 22.72x | 6.43x | 5.84x | |
| 2.06% | 2.19% | 20.87x | 4.67x | 4.29x | |
| 2.31% | 2.44% | 27.66x | 20.89x | 7.14x | |
| 3.78% | 3.76% | 13.33x | 5.65x | 4.82x | |
| 6.05% | 6.1% | 17.83x | 1.85x | 3.37x | |
| Average | 2.71% | 2.79% | 17.22x | -31.29x | 6.26x | |
| Weighted average by Cap. | 2.12% | 2.21% | 23.79x | -40.15x | 7.75x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
